Search Results - "Tolzman, D."

Tacrolimus with Mycophenolate Mofetil (MMF) or Sirolimus vs. Cyclosporine with MMF in Cardiac Transplant Patients: 1‐Year Report by Kobashigawa, J. A., Miller, L. W., Russell, S. D., Ewald, G. A., Zucker, M. J., Goldberg, L. R., Eisen, H. J., Salm, K., Tolzman, D., Gao, J., Fitzsimmons, W., First, R.

“…The most advantageous combination of immunosuppressive agents for cardiac transplant recipients has not yet been established. Between November 2001 and June…”
Get full text

Incidence and type of cancer following the use of OKT3: a single center experience with 557 organ transplants by Batiuk, T D, Barry, J M, Bennett, W M, Meyer, M M, Tolzman, D, Norman, D J

Get more information

Randomized trial of tacrolimus plus mycophenolate mofetil or azathioprine versus cyclosporine oral solution (modified) plus mycophenolate mofetil after cadaveric kidney transplantation : Results at 2 years by AHSAN, Nasimul, JOHNSON, Christopher, SORENSEN, John, MULLOY, Laura, LIGHT, Jimmy, CORWIN, Claudia, DANOVITCH, Gabriel, WACHS, Michael, VANVELDHUISEN, Paul, SALM, Kim, TOLZMAN, Diane, FITZSIMMONS, William E, GONWA, Thomas, HALLORAN, Philip, STEGALL, Mark, HARDY, Mark, METZGER, Robert, SHIELD, Charles III, ROCHER, Leslie, SCANDLING, John

“…A previous report described the 1-year results of a prospective, randomized trial designed to investigate the optimal combination of immunosuppressants in…”
Get full text

Outcome of renal transplantation at Oregon Health Sciences University: 1982 to 1990 by Norman, D J, Bennett, W M, Wetzsteon, P J, Hefty, T, Meyer, M M, Tolzman, D, Seely, M, Millhollen, M, Barry, J M

“…1. Graft survival increased over the 4 periods between 1982 and 1990 (82-84, 85-86, 87-88, 89-90). The largest increase was in the 89-90 period. 2…”
Get more information

Prospective risk stratification in renal transplant candidates for cardiac death by Le, A, Wilson, R, Douek, K, Pulliam, L, Tolzman, D, Norman, D, Barry, J, Bennett, W

“…In previous studies to predict future cardiac death of patients undergoing evaluation for renal transplantation, noninvasive or invasive testing of all, or…”
Get more information

COMPARATIVE TRIAL OF PROGRAF (TACROLIMUS) IN COMBINATION WITH AZATHIOPRINE OR MYCOPHENOLATE MOFETIL VS. NEORAL (CYCLOSPORINE) WITH MYCOPHENOLATE MOFETIL AFTER KIDNEY TRANSPLANTATION by Gonwa, T, Johnson, C, Ahsan, N, Halloran, P, Stegall, M, Hardy, M, Metzger, R, Shield, C, Rocher, L, Scandling, J, Sorense, J, Mulloy, L, Light, J, Corwin, C, Danovitch, G, Wachs, M, Van Veldhuisen, P, Salm, K, Tolzman, D, Fitzsimmons, W

Get full text

TWO YEAR FOLLOWUP OF A RANDOMIZED MULTICENTER KIDNEY TRANSPLANT STUDY COMPARING TACROLIMUS(PG)+AZATHIOPRINE(AZA) VS. CYCLOSPORINE(NEORAL)+MYCOPHENOLATE MOFETIL(MMF) VS. TACROLIMUS+MMF: Abstract# 11 by Gonwa, Thomas A., Johnson, C., Ahsan, N., Halloran, P., Stegall, M., Hardy, M., Metzger, R., Shield, C., Rocher, L., Scandling, J., Sorensen, J., Mulloy, L., Light, J., Corwin, C., Danovitch, G., Wachs, M., VanVeldhuisen, P., Salm, K., Tolzman, D., Scotellaro, P., Fitzsimmons, W.

Get full text

THE ROLE OF ANTIBODY INDUCTION IN SIMULTANEOUS PANCREAS KIDNEY (SPK) TRANSPLANT PATIENTS RECEIVING TACROLIMUS + MYCOPHENOLATE MOFETIL (MMF) IMMUNOSUPPRESSION: Abstract# 357 by Kaufman, D. B., Burke, G., Bruce, D., Sutherland, D., Johnson, C., Gaber, A. O., Merion, R., Schweitzer, E., Marsh, C., Alfrey, E., Leone, J., Concepion, W., Stegall, M., Gores, P., Danovitch, G., Tolzman, D., Scotellaro, P., Salm, K., Keller, A., Fitzsimmons, W. E.

Get full text

Randomized trial of tacrolimus (Prograf) in combination with azathioprine or mycophenolate mofetil versus cyclosporine (Neoral) with mycophenolate mofetil after cadaveric kidney transplantation by Johnson, C, Ahsan, N, Gonwa, T, Halloran, P, Stegall, M, Hardy, M, Metzger, R, Shield, 3rd, C, Rocher, L, Scandling, J, Sorensen, J, Mulloy, L, Light, J, Corwin, C, Danovitch, G, Wachs, M, van Veldhuisen, P, Salm, K, Tolzman, D, Fitzsimmons, W E

“…Our clinical trial was designed to investigate the optimal combination of immunosuppressants for renal transplantation. A randomized three-arm, parallel group,…”
Get full text

Study 1: one-year results of the first prospective, randomized, multicenter kidney transplant study comparing tacrolimus and sirolimus versus tacrolimus and mycophenolate mofetil combination therapy by Mendez, R., Gonwa, T., Rice, K., Holman, M., Yang, H., Filo, R., Steinberg, S., Weinstein, S., Jensik, S., Philosophe, B., Colanna, J., Klein, A., Markowitz, J., Hardy, M., Shield, C., Rajagopalan, P.R., Ketel, B., Barone, G., Concepcion, W., Danovich, G., Tomlanovich, S., Scandling, J., Gores, P., Basadonna, G., Lorber, M., Inokuchi, S., Conti, D., Lake, K., Langnas, A., Kinkhabwala, M., Johnson, C., Johnson, M., Hart, M., Dunn, J., Fitzsimmons, W., Tolzman, D., Harrison, G., Vanveldhuisen, P.

Get full text